< Previous page
All
Airlines/Aviation
Auto
Maritime/Shipbuilding
Transportation
Computer Hardware
Computer Networks
Computer Software
Computer/Electronics
Electronic Commerce
Electronic Components
High Tech Security
Internet Technology
Peripherals
Semiconductors
Electronics Gaming
Consumer Electronics
Mobile Entertainment
Multimedia/Online/Internet
Telecommunications
Household/Consumer/Cosmetics
Retail
Supermarkets
Toys
Alternative Energies
Chemical
Mining/Metals
Oil/Energy
Environmental Products & Services
Green Technology
Art
Cosmetics & Personal Care
Entertainment
Fashion
Film & Motion Picture
Jewelry
Banking/Financial Service
Insurance
Workforce Management/Human Resources
Education
Higher Education
Biotechnology
Health Care/Hospital
Infectious Disease Control
Medical Equipment
Medical/Pharmaceuticals
Agriculture
Machinery
Paper/Forest Products/Containers
Textiles
Domestic policy
Legal issues
Sports
Hotels and Resorts
Leisure/Travel/Hotels
Travel
Restaurants
Beer, Wine & Spirits
Beverages
Non-Alcoholic Beverages
Food/Beverages
Advertising
Books
Music
Publishing/Information Service
Television
Trade show news
Real Estate
Construction/Building
Furniture & Furnishings
|
Title only
|
Print
Next page >
88IV - PR Newswire Asia's news - Health Care/Hospital
5
Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing
PUNE, India , Aug. 4, 2026 /PRNewswire/ -- Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO™), today announced the launch of NeX™, a transformative end-to-end ...
2026-08-04T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
KPJ Healthcare Launches First Orthopaedic and Rheumatology Centre of Excellence Under the KPJ Health System
BUKIT MERTAJAM, Malaysia , Aug. 4, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") today launched its first Orthopaedic and Rheumatology Centre of Excellence ...
2026-08-04T
Biotechnology
Health Care/Hospital
Medical Equipment
Medical/Pharmaceuticals
Human Longevity Makes Clinical-Grade Whole Genome Sequencing Available to All for $599
The same genomic technology once limited to specialist programs is now accessible to anyone, paired with an AI platform built on over a decade of clinical data and a new multimillion-dollar collaboration ...
2026-08-04T
Biotechnology
Health Care/Hospital
Medical Equipment
Medical/Pharmaceuticals
KPJ Healthcare Launches First Orthopaedic and Rheumatology Centre of Excellence Under the KPJ Health System
BUKIT MERTAJAM, Malaysia , Aug. 3, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") today launched its first Orthopaedic and Rheumatology Centre of ...
2026-08-03T
Health Care/Hospital
Medical Equipment
Medical/Pharmaceuticals
Telstra Health Receives Frost & Sullivan's 2026 APAC Company of the Year Recognition for Leadership in Native Healthcare Enterprise Interoperability Platforms
This recognition highlights Telstra Health's innovation, clinician-led approach, and leadership in advancing connected healthcare through FHIR-native interoperability. ...
2026-08-03T
Health Care/Hospital
Medical/Pharmaceuticals
IMG Announces Tenth Annual 'Leave Your Mark' Grant Opportunity
INDIANAPOLIS , Aug. 3, 2026 /PRNewswire/ -- IMG (International Medical Group) is excited to be accepting applications for its annual Leave Your Mark Grant . In its tenth year, the Leave Your ...
2026-08-03T
Banking/Financial Service
Education
Health Care/Hospital
POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure
Anchoring Established Healthcare Operations to Technology-Enabled Growth Opportunities ...
2026-08-03T
Computer/Electronics
Health Care/Hospital
Ascletis Announces Initiation of Global Phase III for Oral Small Molecule GLP-1, ASC30 and Positive Preclinical Data for Its First-in-Class Oral Small Molecule GLP-1/GIP/Amylin Fixed-Dose Combination
-Initiated global Phase III program for oral small molecule GLP-1, ASC30, which will enroll approximately 4,600 participants with obesity or overweight across two pivotal trials in the U.S., Europe, and ...
2026-08-03T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model
SHANGHAI , Aug. 3, 2026 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced ...
2026-08-03T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS
Minjuvi ® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen listed on the Pharmaceutical ...
2026-08-02T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
< Previous page
Next page >
Disclaimer :
In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.